TMO Cited in gRNA Market Report Projecting $2.95B by 2034
What happened
A market analysis published by Custom Market Insights projects the global guide RNA market will reach approximately $2.95 billion by 2034, expanding at a compound annual growth rate of roughly 19%. The report identifies Thermo Fisher Scientific among the leading participants in the space. The gRNA segment is tied to CRISPR-based research tools and therapeutic development, areas where Thermo Fisher supplies reagents, instruments, and genomic workflow solutions.
The QL Read
TMO carries a composite quantitative score of 80/100 against a mixed tape where market breadth sits at 43.8% advancing. Third-party market-sizing data covering a high-growth segment the company serves aligns with the current factor read, though breadth headwinds warrant monitoring.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.